机械通气危重成人患者的保守氧疗:UK-ROX随机临床试验
UK-ROX多中心实用随机试验纳入英国97个ICU的16500例机械通气并接受补氧的成人患者,比较保守氧疗(SpO2目标90%,范围88%-92%,n=8258)与常规氧疗(n=8242)。90天全因死亡率保守组35.4% vs 常规组34.9%,校正后风险差0.7个百分点(95%CI -0.7至2.0;P=0.28),无显著差异。
要点
- 在97个英国ICU的16500例机械通气成人中,保守氧疗未显著降低90天全因死亡率。
- 保守组90天死亡35.4%(2908例)vs 常规组34.9%(2858例),校正风险差0.7个百分点(95%CI -0.7至2.0;P=0.28)。
- ICU停留时间、住院时间、30天无器官支持存活天数及其他时间点死亡率均无显著差异。
核心结论
- 在ICU接受机械通气和补氧的成人患者中,通过保守氧疗最小化氧暴露未显著降低90天全因死亡率。
研究设计与样本
- 多中心、实用性、随机临床试验,在英国97个ICU开展,纳入16500例接受补氧的机械通气成人患者,2021年5月至2024年11月入组,2025年2月完成随访。
- 保守氧疗组8258例接受维持SpO2在90%的最低吸入氧浓度,常规氧疗组8242例由治疗临床医生酌情给氧。
主要发现
- 保守氧疗组补氧暴露较常规氧疗组低29%。
- 90天时保守氧疗组2908例(35.4%)死亡,常规氧疗组2858例(34.9%)死亡;校正预设基线变量后风险差0.7个百分点(95%CI -0.7至2.0;P=0.28)。
- ICU停留时间、急性住院时间、30天无器官支持存活天数及其他时间点死亡率均无显著差异。
关键数值与推荐
- 主要结局为90天全因死亡率,保守氧疗组35.4% vs 常规氧疗组34.9%,校正风险差0.7个百分点(95%CI -0.7至2.0;P=0.28)。
- 保守氧疗策略的SpO2目标为90%(范围88%-92%)。
临床怎么用
- 原文结论为在ICU接受机械通气和补氧的成人患者中,保守氧疗未显著降低90天全因死亡率,原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Supplemental oxygen is frequently given to patients in intensive care units (ICUs); however, there is insufficient evidence to guide its therapeutic use and to minimize the potential harm caused by administering too little or too much. OBJECTIVE: To determine whether reducing exposure to supplemental oxygen through a strategy of conservative oxygen therapy by using a peripheral oxygen saturation (Spo2) target of 90% (range, 88%-92%) reduces mortality at 90 days in mechanically ventilated adult patients receiving supplemental oxygen in the ICU. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, pragmatic, randomized clinical trial conducted in 97 ICUs in the UK including 16 500 mechanically ventilated patients receiving supplemental oxygen. Participants were enrolled between May 2021 and November 2024. Follow-up was completed in February 2025. INTERVENTIONS: Participants randomized to conservative oxygen therapy (n = 8258) received the lowest fraction of inspired oxygen possible to maintain their Spo2 at 90%. Participants randomized to usual oxygen therapy (n = 8242) received oxygen therapy at the discretion of the treating clinician. MAIN OUTCOMES AND MEASURES: The primary outcome was all-cause mortality at 90 days. Secondary outcomes included duration of ICU and acute hospital stay among survivors, days alive and free from organ support at 30 days, and mortality at other time points. RESULTS: Of 16 500 randomized patients, primary outcome data were available for 16 394 (8211 in the conservative and 8183 in the usual oxygen therapy group). Randomized groups were similar (median age, 60 [IQR, 48-71] years and 38.2% females in both groups [n = 5652]). Exposure to supplemental oxygen was 29% lower for participants in the conservative oxygen therapy group compared with the usual oxygen therapy group. By 90 days, 2908 participants (35.4%) in the conservative oxygen therapy group had died compared with 2858 (34.9%) in the usual oxygen therapy group. After adjustment for prespecified baseline variables, the risk difference was 0.7 percentage points (95% CI, -0.7 to 2.0; P = .28). There were no significant differences in durations in ICU or hospital stay, days alive and free from organ support at 30 days, or mortality at other time points. CONCLUSIONS AND RELEVANCE: In adult patients receiving mechanical ventilation and supplemental oxygen in the ICU, minimizing oxygen exposure through conservative oxygen therapy did not significantly reduce all-cause mortality at 90 days. TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN13384956.
引用
- Martin DS, Gould DW, Shahid T, et al. Conservative Oxygen Therapy in Mechanically Ventilated Critically Ill Adult Patients: The UK-ROX Randomized Clinical Trial. JAMA. 2025. PMID: 40501321. doi:10.1001/jama.2025.9663
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。